TCM
IPSC icon

Tang Capital Management’s Century Therapeutics IPSC Stock Holding History

Tang Capital Management’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-900,000
Closed -$448K – 131
2025
Q3 		$448K Hold
900,000
– – 0.02% 181
2025
Q2 		$503K Hold
900,000
– – 0.03% 187
2025
Q1 		$428K Hold
900,000
– – 0.02% 188
2024
Q4 		$909K Hold
900,000
– – 0.06% 157
2024
Q3 		$1.54M Hold
900,000
– – 0.11% 100
2024
Q2 		$2.29M Hold
900,000
– – 0.23% 76
2024
Q1 		$3.76M Sell
900,000
-166,440
-16% -$704K 0.39% 65
2023
Q4 		$3.54M Buy
+1,066,440
New +$1.94M 0.33% 72

Other funds holding IPSC

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return